# Pulmonary Tuberculosis: Developing Drugs for Treatment - FDA Guidance Document

Source: https://www.keypedia.com/guidances/guidance-document/pulmonary-tuberculosis-developing-drugs-for-treatment/8b46de55-ddca-4887-a2ad-5d46be5633aa

> FDA guidance document: Pulmonary Tuberculosis: Developing Drugs for Treatment. Issue date: December 14, 2022. Get complete insights and analysis.

---

## Details

- Title: Pulmonary Tuberculosis: Developing Drugs for Treatment
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2022-12-14
- Comment Close Date: 2023-02-13
- Last Changed: 2022-12-19
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2013-D-1319">FDA-2013-D-1319</a>

## Related Documents

- [Erosive Esophagitis: Developing Drugs for Treatment](https://www.keypedia.com/guidances/guidance-document/erosive-esophagitis-developing-drugs-for-treatment/985e94e3-4616-49e9-822e-0854256bb10e)
- [Crohn’s Disease:  Developing Drugs for Treatment](https://www.keypedia.com/guidances/guidance-document/crohns-disease-developing-drugs-for-treatment/10ab5c94-72ed-489d-b2cc-24cf6914fed5)
- [Gastroparesis: Clinical Evaluation of Drugs for Treatment Guidance for Industry](https://www.keypedia.com/guidances/guidance-document/gastroparesis-clinical-evaluation-of-drugs-for-treatment-guidance-for-industry/4b7bc445-8e11-4ce8-a6d6-3439f06daab5)